Trials / Unknown
UnknownNCT03108430
Study of Risk Factors for Developing Inhalation Pneumonia After Inhalation
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Inhalation pneumonia (PI) is common in clinical practice but is rarely studied. For example, there are no data on the incidence of pneumonia after inhalation and risk factors or protective factors to develop one since it is known that anyone who inhaled does not necessarily develop an IP. There is no data on the benefit of treating inhalation by antibiotic therapy pre-emptively although this practice is common. In this context, this observational study wishes to take stock of the situation on the subject in order to determine what actions to implement to prevent IP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Risk factors and incidence of IP after inhalation | Calculate the annual incidence of PI, the incidence of PI in inhaled patients (in each subgroup), and analyze the risk factors by logistic regression, based on the number of patients hospitalized during the study period. |
Timeline
- Start date
- 2016-08-22
- Primary completion
- 2017-08-21
- Completion
- 2017-08-21
- First posted
- 2017-04-11
- Last updated
- 2017-04-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03108430. Inclusion in this directory is not an endorsement.